Contact Us

Scott Gottlieb on the Future of Cancer Treatment

Thought Leader: Scott Gottlieb
August 23, 2026

Former FDA Commissioner Dr. Scott Gottlieb joined Face the Nation with Margaret Brennan to discuss several major developments shaping healthcare and public health policy. Gottlieb highlighted promising research involving an experimental mRNA treatment for high-risk melanoma, explaining that while it is often described as a cancer vaccine, it is more accurately a form of cancer immunotherapy. The approach uses mRNA to help train the immune system to recognize proteins associated with cancer cells, potentially allowing the body to identify and fight cancer if it returns.

Gottlieb also addressed the FDA’s handling of recent foodborne illness outbreaks and the administration’s selection of Dr. Heidi Overton to lead the agency. Drawing on his experience as FDA Commissioner, he offered perspective on how food-safety performance should be evaluated and emphasized the importance of strong policy leadership, scientific credibility, and experienced personnel at the FDA.

With his ability to translate complex developments in medicine, regulation, and public health into clear insights for audiences, Dr. Scott Gottlieb brings an invaluable perspective to conferences and events. His experience at the highest levels of government and healthcare gives leaders a better understanding of the forces shaping the future of the industry. To learn more about hosting Dr. Scott Gottlieb, contact WWSG.

Relevant posts

Subscribe to the WWSG newsletter.

Check Availability

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

0
Speaker List
Share My List